{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T06:01:03Z","timestamp":1776924063894,"version":"3.51.2"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the foundation of \u201cTianshan Elite\u201d Training Program of Xinjiang Uygur Autonomous Region","award":["2023TSYCCX0047"],"award-info":[{"award-number":["2023TSYCCX0047"]}]},{"name":"the foundation of \u201cTianshan Elite\u201d Training Program of Xinjiang Uygur Autonomous Region","award":["2023TSYCCX0047"],"award-info":[{"award-number":["2023TSYCCX0047"]}]},{"name":"the foundation of \u201cTianshan Elite\u201d Training Program of Xinjiang Uygur Autonomous Region","award":["2023TSYCCX0047"],"award-info":[{"award-number":["2023TSYCCX0047"]}]},{"name":"the foundation of \u201cTianshan Elite\u201d Training Program of Xinjiang Uygur Autonomous Region","award":["2023TSYCCX0047"],"award-info":[{"award-number":["2023TSYCCX0047"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77019-z","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T14:07:29Z","timestamp":1730297249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The prognostic impact of stress hyperglycemia ratio for all-cause mortality in patients with Psoriasis"],"prefix":"10.1038","volume":"14","author":[{"given":"Guliziba","family":"Tuersun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiasuer","family":"Alifu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"issue":"6","key":"77019_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1056\/NEJMe2314345","volume":"390","author":"JM Gelfand","year":"2024","unstructured":"Gelfand, J. M. Psoriasis - More Progress but More Questions. N Engl J Med 390(6), 561\u20132 (2024).","journal-title":"N Engl J Med"},{"issue":"9","key":"77019_CR2","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1001\/jamadermatol.2014.1019","volume":"150","author":"AW Armstrong","year":"2014","unstructured":"Armstrong, A. W. Psoriasis provoked or exacerbated by medications: identifying culprit drugs. JAMA Dermatol 150(9), 963 (2014).","journal-title":"JAMA Dermatol"},{"issue":"19","key":"77019_CR3","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong, A. W. & Read, C. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. JAMA 323(19), 1945\u201360 (2020).","journal-title":"JAMA"},{"issue":"5 Suppl 93","key":"77019_CR4","first-page":"S2","volume":"33","author":"W Alwan","year":"2015","unstructured":"Alwan, W. & Nestle, F. O. Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine. Clin Exp Rheumatol 33(5 Suppl 93), S2-6 (2015).","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"77019_CR5","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jid.2017.07.841","volume":"138","author":"MH Noe","year":"2018","unstructured":"Noe, M. H., Shin, D. B., Wan, M. T. & Gelfand, J. M. Objective Measures of Psoriasis Severity Predict Mortality: A Prospective Population-Based Cohort Study. J Invest Dermatol 138(1), 228\u201330 (2018).","journal-title":"J Invest Dermatol"},{"issue":"14","key":"77019_CR6","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","volume":"296","author":"JM Gelfand","year":"2006","unstructured":"Gelfand, J. M. et al. Risk of myocardial infarction in patients with psoriasis. JAMA 296(14), 1735\u201341 (2006).","journal-title":"JAMA"},{"issue":"4","key":"77019_CR7","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","volume":"80","author":"CA Elmets","year":"2019","unstructured":"Elmets, C. A. et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol 80(4), 1073\u2013113 (2019).","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"77019_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jaad.2019.08.011","volume":"85","author":"YR Semenov","year":"2021","unstructured":"Semenov, Y. R. et al. Psoriasis and mortality in the United States: Data from the National Health and Nutrition Examination Survey. J Am Acad Dermatol 85(2), 396\u2013403 (2021).","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"77019_CR9","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.jacc.2019.03.009","volume":"74","author":"DK Arnett","year":"2019","unstructured":"Arnett, D. K. et al. 2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 74(10), 1376\u2013414 (2019).","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"77019_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/jdv.15159","volume":"33","author":"JM Fernandez-Armenteros","year":"2019","unstructured":"Fernandez-Armenteros, J. M. et al. Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study. J Eur Acad Dermatol Venereol 33(1), 128\u201335 (2019).","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"20","key":"77019_CR11","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1001\/jama.2020.21749","volume":"324","author":"AH Krist","year":"2020","unstructured":"USPST et al. Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: US Preventive Services Task Force Recommendation Statement. JAMA 324(20), 2069\u201375 (2020).","journal-title":"JAMA"},{"issue":"10258","key":"77019_CR12","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"Diseases GBD","year":"2020","unstructured":"Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396(10258), 1204\u201322 (2020).","journal-title":"Lancet"},{"issue":"9206","key":"77019_CR13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0140-6736(99)08415-9","volume":"355","author":"SE Capes","year":"2000","unstructured":"Capes, S. E., Hunt, D., Malmberg, K. & Gerstein, H. C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355(9206), 773\u20138 (2000).","journal-title":"Lancet"},{"issue":"4","key":"77019_CR14","doi-asserted-by":"publisher","first-page":"847","DOI":"10.2337\/dc17-1732","volume":"41","author":"G Marenzi","year":"2018","unstructured":"Marenzi, G. et al. Prognostic Value of the Acute-to-Chronic Glycemic Ratio at Admission in Acute Myocardial Infarction: A Prospective Study. Diabetes Care 41(4), 847\u201353 (2018).","journal-title":"Diabetes Care"},{"issue":"2","key":"77019_CR15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/cc12514","volume":"17","author":"PE Marik","year":"2013","unstructured":"Marik, P. E. & Bellomo, R. Stress hyperglycemia: an essential survival response!\u00a0Crit Care 17(2), 305 (2013).","journal-title":"Crit Care"},{"issue":"9677","key":"77019_CR16","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/S0140-6736(09)60553-5","volume":"373","author":"KM Dungan","year":"2009","unstructured":"Dungan, K. M., Braithwaite, S. S. & Preiser, J. C. Stress hyperglycaemia. Lancet 373(9677), 1798\u2013807 (2009).","journal-title":"Lancet"},{"issue":"12","key":"77019_CR17","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1210\/jc.2015-2660","volume":"100","author":"GW Roberts","year":"2015","unstructured":"Roberts, G. W. et al. Relative Hyperglycemia, a Marker of Critical Illness: Introducing the Stress Hyperglycemia Ratio. J Clin Endocrinol Metab 100(12), 4490\u20137 (2015).","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"77019_CR18","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2337\/dc21-1526","volume":"45","author":"J Yang","year":"2022","unstructured":"Yang, J. et al. The Impact of the Stress Hyperglycemia Ratio on Short-term and Long-term Poor Prognosis in Patients With Acute Coronary Syndrome: Insight From a Large Cohort Study in Asia. Diabetes Care 45(4), 947\u201356 (2022).","journal-title":"Diabetes Care"},{"issue":"7","key":"77019_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/1753-0407.13400","volume":"15","author":"G Zeng","year":"2023","unstructured":"Zeng, G. et al. Stress hyperglycemia ratio and long-term prognosis in patients with acute coronary syndrome: A multicenter, nationwide study. J Diabetes 15(7), 557\u201368 (2023).","journal-title":"J Diabetes"},{"issue":"1","key":"77019_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12933-021-01395-3","volume":"20","author":"CH Sia","year":"2021","unstructured":"Sia, C. H. et al. Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients. Cardiovasc Diabetol 20(1), 211 (2021).","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"77019_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12933-023-01790-y","volume":"22","author":"M Wang","year":"2023","unstructured":"Wang, M., Su, W., Cao, N., Chen, H. & Li, H. Prognostic implication of stress hyperglycemia in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Cardiovasc Diabetol 22(1), 63 (2023).","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"77019_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12933-023-01742-6","volume":"22","author":"FA Abdu","year":"2023","unstructured":"Abdu, F. A. et al. Association of stress hyperglycemia ratio and poor long-term prognosis in patients with myocardial infarction with non-obstructive coronary arteries. Cardiovasc Diabetol 22(1), 11 (2023).","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"77019_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12933-022-01645-y","volume":"21","author":"W Xu","year":"2022","unstructured":"Xu, W. et al. Association of stress hyperglycemia ratio and in-hospital mortality in patients with coronary artery disease: insights from a large cohort study. Cardiovasc Diabetol 21(1), 217 (2022).","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"77019_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12933-022-01479-8","volume":"21","author":"W Xu","year":"2022","unstructured":"Xu, W. et al. Predictive value of the stress hyperglycemia ratio in patients with acute ST-segment elevation myocardial infarction: insights from a multi-center observational study. Cardiovasc Diabetol 21(1), 48 (2022).","journal-title":"Cardiovasc Diabetol"},{"issue":"10275","key":"77019_CR25","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi, K., Balato, A., Enerback, C. & Sabat, R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet 397(10275), 754\u201366 (2021).","journal-title":"Lancet"},{"issue":"2","key":"77019_CR26","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/jdv.18720","volume":"37","author":"JC Prinz","year":"2023","unstructured":"Prinz, J. C. et al. Prevalence, comorbidities and mortality of generalized pustular psoriasis: A literature review. J Eur Acad Dermatol Venereol 37(2), 256\u201373 (2023).","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"77019_CR27","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/jid.2010.399","volume":"131","author":"RS Stern","year":"2011","unstructured":"Stern, R. S. & Huibregtse, A. Very severe psoriasis is associated with increased noncardiovascular mortality but not with increased cardiovascular risk. J Invest Dermatol 131(5), 1159\u201366 (2011).","journal-title":"J Invest Dermatol"},{"issue":"3","key":"77019_CR28","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/bjd.15021","volume":"176","author":"DA Springate","year":"2017","unstructured":"Springate, D. A. et al. Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study. Br J Dermatol 176(3), 650\u20138 (2017).","journal-title":"Br J Dermatol"},{"issue":"1","key":"77019_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/bjd.16919","volume":"180","author":"L Skov","year":"2019","unstructured":"Skov, L. et al. Cause-specific mortality in patients with psoriasis and psoriatic arthritis. Br J Dermatol 180(1), 100\u20137 (2019).","journal-title":"Br J Dermatol"},{"issue":"5","key":"77019_CR30","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.jaad.2018.12.037","volume":"80","author":"A Dhana","year":"2019","unstructured":"Dhana, A., Yen, H., Yen, H. & Cho, E. All-cause and cause-specific mortality in psoriasis: A systematic review and meta-analysis. J Am Acad Dermatol 80(5), 1332\u201343 (2019).","journal-title":"J Am Acad Dermatol"},{"key":"77019_CR31","doi-asserted-by":"publisher","first-page":"101783","DOI":"10.1016\/j.eclinm.2022.101783","volume":"56","author":"R Chang","year":"2023","unstructured":"Chang, R. et al. Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study. EClinicalMedicine 56, 101783 (2023).","journal-title":"EClinicalMedicine"},{"issue":"5","key":"77019_CR32","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.jaad.2020.10.031","volume":"84","author":"K Colaco","year":"2021","unstructured":"Colaco, K. et al. Trends in mortality and cause-specific mortality among patients with psoriasis and psoriatic arthritis in Ontario. Canada. J Am Acad Dermatol 84(5), 1302\u20139 (2021).","journal-title":"Canada. J Am Acad Dermatol"},{"issue":"7","key":"77019_CR33","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/jid.2010.103","volume":"130","author":"BB Davidovici","year":"2010","unstructured":"Davidovici, B. B. et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 130(7), 1785\u201396 (2010).","journal-title":"J Invest Dermatol"},{"issue":"2","key":"77019_CR34","first-page":"e13","volume":"24","author":"SM Grundy","year":"2004","unstructured":"Grundy, S. M. et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24(2), e13-8 (2004).","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"16","key":"77019_CR35","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti, K. G. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16), 1640\u20135 (2009).","journal-title":"Circulation"},{"issue":"1","key":"77019_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12933-023-01812-9","volume":"22","author":"QC Wei","year":"2023","unstructured":"Wei, Q. C. et al. Association of stress hyperglycemia with clinical outcomes in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention: a cohort study. Cardiovasc Diabetol 22(1), 85 (2023).","journal-title":"Cardiovasc Diabetol"},{"key":"77019_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.metabol.2016.11.011","volume":"67","author":"K Tziomalos","year":"2017","unstructured":"Tziomalos, K. et al. Stress hyperglycemia and acute ischemic stroke in-hospital outcome. Metabolism 67, 99\u2013105 (2017).","journal-title":"Metabolism"},{"issue":"10","key":"77019_CR38","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1161\/hs1001.096194","volume":"32","author":"SE Capes","year":"2001","unstructured":"Capes, S. E., Hunt, D., Malmberg, K., Pathak, P. & Gerstein, H. C. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32(10), 2426\u201332 (2001).","journal-title":"Stroke"},{"issue":"1","key":"77019_CR39","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12933-023-01908-2","volume":"22","author":"Q Zhou","year":"2023","unstructured":"Zhou, Q. et al. The impact of the stress hyperglycemia ratio on mortality and rehospitalization rate in patients with acute decompensated heart failure and diabetes. Cardiovasc Diabetol 22(1), 189 (2023).","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"77019_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12933-023-01759-x","volume":"22","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Association between the stress hyperglycemia ratio and severity of coronary artery disease under different glucose metabolic states. Cardiovasc Diabetol 22(1), 29 (2023).","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"77019_CR41","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12933-022-01728-w","volume":"21","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y. et al. \u2018Stress hyperglycemia ratio and in-hospital prognosis in non-surgical patients with heart failure and type 2 diabetes. Cardiovasc Diabetol 21(1), 290 (2022).","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"77019_CR42","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1080\/07853890.2023.2186479","volume":"55","author":"S Gao","year":"2023","unstructured":"Gao, S., Huang, S., Lin, X., Xu, L. & Yu, M. Prognostic implications of stress hyperglycemia ratio in patients with myocardial infarction with nonobstructive coronary arteries. Ann Med 55(1), 990\u20139 (2023).","journal-title":"Ann Med"},{"issue":"6","key":"77019_CR43","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.jaad.2021.06.008","volume":"86","author":"H Miyachi","year":"2022","unstructured":"Miyachi, H. et al. Treatments and outcomes of generalized pustular psoriasis: A cohort of 1516 patients in a nationwide inpatient database in Japan. J Am Acad Dermatol 86(6), 1266\u201374 (2022).","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"77019_CR44","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/hep.20305","volume":"40","author":"M Viguier","year":"2004","unstructured":"Viguier, M. et al. High frequency of cholestasis in generalized pustular psoriasis: Evidence for neutrophilic involvement of the biliary tract. Hepatology 40(2), 452\u20138 (2004).","journal-title":"Hepatology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77019-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77019-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77019-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T14:57:11Z","timestamp":1730300231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77019-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77019"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77019-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"27 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NHANES is conducted by the Centers for Disease Control and Prevention (CDC) and the National Center for Health Statistics (NCHS). The NCHS Research Ethics Review Committee reviewed and approved the NHANES study protocol. All participants signed written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26113"}}